Iron Sucrose Injection
Sponsors
American Regent, Inc., St. Bartholomew's Hospital, Assiut University, Ruijin Hospital, Baxter Healthcare Corporation
Conditions
AnemiaBioequivalanceIron Deficiency Anemia (IDA)Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney DiseaseLeukemiaLung NeoplasmLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Phase 1
Phase 2
Phase 3
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer
NCT00482716
Start: 2007-01-31Target: 80Updated: 2014-01-10
Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia
CompletedNCT03009578
Start: 2017-02-01End: 2018-06-05Updated: 2018-07-03
Phase 4
Unknown Phase
Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining
CompletedNCT03516500
Start: 2018-05-09End: 2021-01-21Updated: 2021-08-31
Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients
RecruitingNCT06994065
Start: 2025-06-02End: 2025-09-30Target: 128Updated: 2025-08-12